Drug profile · INN
erythromycin gluceptate
ILOTYCIN GLUCEPTATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
erythromycin gluceptate (ILOTYCIN GLUCEPTATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN erythromycin gluceptate
Brand ILOTYCIN GLUCEPTATE
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is erythromycin gluceptate?
erythromycin gluceptate (ILOTYCIN GLUCEPTATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for erythromycin gluceptate?
ILOTYCIN GLUCEPTATE is a marketed brand name for erythromycin gluceptate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of erythromycin gluceptate?
erythromycin gluceptate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.